Osteomyelitis
Infection of bone -most commonly S. aureus. Hematogenous in children, contiguous spread in adults (diabetic foot, decubitus ulcers, post-surgical). MRI is the imaging gold standard. Bone biopsy is the diagnostic gold standard. Treatment is 6 weeks of targeted antibiotics -oral step-down is non-inferior to IV (OVIVA 2019).
🔍 Overview
Classification
| Type | Mechanism | Typical Patient | Common Organisms |
|---|---|---|---|
| Hematogenous | Bacteremia seeds bone (metaphysis in children, vertebral body in adults) | Children, IVDU (vertebral), sickle cell disease | S. aureus (#1 overall). Salmonella in SCD. Pseudomonas in IVDU. |
| Contiguous spread | Direct extension from adjacent soft tissue infection, open fracture, or surgery | Post-surgical, trauma, diabetic foot ulcers, decubitus ulcers | S. aureus, coagulase-negative staph (hardware). Polymicrobial (diabetic foot -add gram-negatives + anaerobes). |
| Vascular insufficiency | Chronic ischemia + minor trauma/ulceration → infection spreads to bone | Diabetic foot, peripheral arterial disease | Polymicrobial: S. aureus, Streptococcus, Enterococcus, gram-negatives (E. coli, Proteus), anaerobes (Bacteroides). |
Acute vs Chronic
| Feature | Acute | Chronic |
|---|---|---|
| Duration | < 2 weeks of symptoms | > 6 weeks, or recurrent |
| Pathology | Suppurative infection, edema | Sequestrum (dead bone), involucrum (new bone around dead bone), sinus tracts |
| Treatment | Antibiotics often curative alone | Usually requires surgical debridement + prolonged antibiotics |
Probe-to-bone test: In diabetic foot ulcers, if a sterile metal probe reaches bone through the ulcer, the positive predictive value for osteomyelitis is ~89%. Simple, bedside, no imaging needed.
🚨 Management
Antibiotic Duration
Standard: 6 weeks of targeted antibiotics. Oral step-down after initial IV is acceptable -OVIVA trial showed oral antibiotics were non-inferior to IV for bone and joint infections at 1 year OVIVA, 2019.
Empiric Therapy (Before Culture Data)
| Scenario | Empiric Regimen | Rationale |
|---|---|---|
| Native bone, acute | Vancomycin (Vancocin) (MRSA coverage) + Ceftriaxone (Rocephin) 2g IV daily (gram-negatives) | Covers MRSA + gram-negatives while awaiting cultures. Narrow once sensitivities return. |
| Diabetic foot | Vancomycin (Vancocin) + Piperacillin-tazobactam (Zosyn) 3.375g IV q6h | Polymicrobial -need MRSA + gram-negatives + anaerobic coverage. |
| Post-surgical / hardware | Vancomycin (Vancocin) + Cefepime (Maxipime) 2g IV q8h | Covers MRSA + Pseudomonas + skin flora. Hardware infections often need surgical removal. |
| Vertebral | Vancomycin (Vancocin) + Ceftriaxone (Rocephin) | S. aureus is #1. If IVDU, cover Pseudomonas (use cefepime instead of ceftriaxone). |
| Sickle cell disease | Ceftriaxone (Rocephin) 2g IV daily | Salmonella is #1 in SCD (not S. aureus). Ceftriaxone covers Salmonella + S. aureus. |
Surgical Indications
- Chronic osteomyelitis with sequestrum or sinus tracts
- Failed medical therapy (persistent infection after adequate antibiotics)
- Hardware-associated infection -often requires implant removal
- Abscess requiring drainage
- Spinal epidural abscess with neurological compromise -neurosurgical emergency
- Diabetic foot with non-healing ulcer and extensive bony involvement -may need amputation
Do NOT start antibiotics before bone biopsy/cultures if the patient is stable. Pre-biopsy antibiotics reduce culture yield and may lead to months of unnecessarily broad therapy. Exception: septic or hemodynamically unstable patients -treat empirically, culture what you can.
🧪 Workup
Diagnostic Evaluation
- ESR and CRP -elevated in >90% of cases. ESR >70 is highly suggestive. Use to monitor treatment response.
- Blood cultures (×2 sets) -positive in ~50% of hematogenous osteomyelitis. Always obtain before antibiotics.
- CBC -WBC may be normal in chronic osteomyelitis. Left shift suggests acute infection.
- Plain radiographs -first-line imaging. Changes take 10–14 days to appear (periosteal reaction, lytic lesions). Normal X-ray does NOT rule out early osteomyelitis.
- MRI with gadolinium -imaging gold standard. Sensitivity 90–100%, specificity 80–90%. Shows bone marrow edema, soft tissue extent, abscess.
- Bone biopsy with culture -diagnostic gold standard. Identifies organism and sensitivities. Essential for targeted therapy. IR-guided or open surgical.
- Probe-to-bone test -bedside test for diabetic foot ulcers. PPV ~89% if positive.
MRI cannot distinguish osteomyelitis from Charcot arthropathy in diabetic feet -both show bone marrow edema. Clinical correlation and biopsy are essential in this setting.
💊 Medications
Targeted Therapy (Based on Culture)
| Organism | First-Line | Alternative | Duration / Notes |
|---|---|---|---|
| MSSA* *= Methicillin-Sensitive Staph aureus | Nafcillin (Nallpen) 2g IV q4h or Cefazolin (Ancef) 2g IV q8h | Oral step-down: Cephalexin (Keflex) 1g PO QID or Dicloxacillin (Dynapen) 500mg PO QID | 6 weeks. IV × 1–2 weeks then oral step-down per OVIVA. Cefazolin preferred for ease of outpatient dosing (q8h vs q4h). |
| MRSA* *= Methicillin-Resistant Staph aureus | Vancomycin (Vancocin) 15–20 mg/kg IV q8–12h (target AUC/MIC 400–600) | Oral step-down: TMP-SMX (Bactrim) DS 1–2 tabs PO BID + Rifampin (Rifadin) 300mg PO BID | 6 weeks. Rifampin for biofilm penetration (hardware infections). Never use rifampin monotherapy -resistance develops rapidly. |
| Streptococcus | Ceftriaxone (Rocephin) 2g IV daily | Penicillin G or Amoxicillin (Amoxil) 1g PO TID | 6 weeks. Strep are reliably penicillin-sensitive. |
| Pseudomonas | Cefepime (Maxipime) 2g IV q8h or Piperacillin-tazobactam (Zosyn) | Ciprofloxacin (Cipro) 750mg PO BID (oral option with good bone penetration) | 6 weeks. Cipro has excellent oral bioavailability and bone penetration -preferred oral agent for Pseudomonas osteo. |
| Salmonella (SCD) | Ceftriaxone (Rocephin) 2g IV daily | Ciprofloxacin (Cipro) 500mg PO BID | 6 weeks. Most common cause of osteomyelitis in sickle cell disease. |
| Polymicrobial (diabetic foot) | Vancomycin (Vancocin) + Piperacillin-tazobactam (Zosyn) | Oral step-down: Amoxicillin-clavulanate (Augmentin) 875mg PO BID + TMP-SMX (Bactrim) (if MRSA) | 6 weeks. Surgical debridement is almost always needed. Vascular assessment essential. |
📋 On Rounds
Pimp Questions
What is the most common organism causing osteomyelitis overall? In sickle cell disease?
Overall: S. aureus -accounts for ~60% of all osteomyelitis. In sickle cell disease: Salmonella -infarcted bone from vaso-occlusive crises is a perfect growth medium. This is a classic boards distinction. However, S. aureus is still #1 for septic arthritis in SCD.
Why is bone biopsy considered the gold standard over blood cultures?
Blood cultures are positive in only ~50% of hematogenous osteomyelitis and even less in contiguous spread. Bone biopsy with culture identifies the exact organism and sensitivities, allowing targeted narrow-spectrum therapy for a 6-week course. Without culture data, you may commit a patient to 6 weeks of unnecessarily broad-spectrum antibiotics with more side effects, higher cost, and greater resistance risk.
Can you treat osteomyelitis with oral antibiotics?
Yes. The OVIVA trial (2019) randomized 1,054 patients with bone/joint infections to IV vs oral antibiotics after initial surgical management. Oral was non-inferior at 1 year (treatment failure 14.6% oral vs 14.1% IV). Key caveat: patients had a defined organism with known oral sensitivities, and oral agents with good bone penetration were used (fluoroquinolones, rifampin combinations, linezolid).
Why should you never use rifampin as monotherapy?
Rifampin has excellent biofilm penetration (critical for hardware-associated infections) and good bone penetration. However, resistance develops extremely rapidly with monotherapy -single-step mutations in the rpoB gene occur at a rate of ~10⁻⁸, which is high enough to select resistant mutants within days. Always combine with another active agent (e.g., TMP-SMX, fluoroquinolone, vancomycin).
Clinical Examples
📋 Case 1, Vertebral Osteomyelitis from Bacteremia
Patient: 62M IVDU with 3 weeks of progressive back pain and low-grade fevers. MRI spine: L3-L4 vertebral body edema, disc enhancement, paravertebral phlegmon. Blood cultures: MSSA. No epidural abscess.
Key findings: Vertebral osteomyelitis (most common location for hematogenous osteomyelitis in adults). IVDU + S. aureus bacteremia. Must rule out epidural abscess (MRI with contrast is the gold standard). No surgical indication without abscess or instability.
Management:
- Nafcillin 2g IV q4h × 6 weeks (MSSA → beta-lactam preferred over vancomycin for efficacy)
- Add rifampin 300 mg PO BID after 2 weeks of IV therapy (enhances biofilm penetration, always in combination, never alone)
- TTE → if positive or high suspicion: TEE to rule out endocarditis (IVDU + S. aureus = 30% concurrent IE)
- Pain management: NSAIDs + acetaminophen; opioids PRN initially; gabapentin for neuropathic component
- PICC line for outpatient IV antibiotics (OPAT) if clinically stable after initial improvement
Teaching point: Every case of vertebral osteomyelitis needs an MRI of the ENTIRE spine (multifocal in 10-15%) and evaluation for endocarditis (especially S. aureus). Blood cultures are positive in 50-60%, get them before antibiotics.
📋 Case 2, Diabetic Foot Osteomyelitis
Patient: 68M with T2DM (A1c 10.2), presents with non-healing plantar ulcer × 3 months over 2nd metatarsal head. Ulcer depth: bone is palpable with sterile probe ("probe to bone" positive). XR: periosteal reaction and cortical erosion of 2nd metatarsal.
Key findings: Diabetic foot osteomyelitis, "probe to bone" test has 89% PPV for osteomyelitis when positive in a diabetic foot ulcer. X-ray changes confirm chronic osteomyelitis (periosteal reaction, cortical destruction).
Management:
- MRI foot (best imaging) to delineate extent of bone involvement and surgical planning
- Bone biopsy + culture before antibiotics if possible (wound swabs are unreliable, contaminated with skin flora)
- Empiric: vancomycin + piperacillin-tazobactam (cover MRSA + GNR + anaerobes) → narrow based on bone culture
- Surgical debridement or limited amputation (ray amputation) for devitalized bone, antibiotics alone cannot cure dead bone
- Offloading: total contact cast or removable walking boot (pressure relief is essential for healing)
Teaching point: Wound swab cultures do NOT reflect bone pathogens, bone biopsy is the gold standard for guiding antibiotic therapy. If bone is visible or palpable in a diabetic foot ulcer, treat as osteomyelitis. MRI is the best imaging modality (sensitivity 90%, specificity 80%).
📋 Case 3, Prosthetic Joint Infection
Patient: 74F, 2 years post-right TKR. Progressive knee pain and swelling × 6 weeks, low-grade fever. Knee aspirate: WBC 28,000 (80% PMNs), culture growing coagulase-negative Staph (CoNS). CRP 68, ESR 82.
Key findings: Chronic prosthetic joint infection (PJI), onset > 3 months post-op. CoNS is #1 organism in chronic PJI (biofilm former on prosthetic material). Synovial WBC > 3,000 with > 80% PMNs meets MSIS criteria for PJI in a prosthetic joint.
Management:
- Two-stage exchange arthroplasty (gold standard for chronic PJI): remove prosthesis → antibiotic spacer × 6-8 weeks → reimplant new prosthesis
- IV vancomycin × 6 weeks (CoNS, often methicillin-resistant) + rifampin 300 mg PO BID (biofilm penetration)
- Alternative (select cases): DAIR (debridement, antibiotics, implant retention) if: < 3 weeks of symptoms, stable implant, susceptible organism
- ID consult for antibiotic optimization and duration
- Withhold reimplantation until CRP normalizes and repeat aspiration is negative
Teaching point: Rifampin is the key drug in prosthetic joint infections, it penetrates biofilms that other antibiotics cannot reach. But NEVER use rifampin alone (rapid resistance in days). Always combine with vancomycin, TMP-SMX, or a fluoroquinolone.
📣 Sample Presentation
One-Liner
"Mrs. Garcia is a 62-year-old woman with poorly controlled diabetes (A1c 9.8%) and a non-healing right plantar ulcer × 3 months, now with exposed bone on probing and MRI showing marrow edema in the 2nd metatarsal head consistent with osteomyelitis."
Key Points to Cover on Rounds
Diabetic foot ulcer with positive probe-to-bone. MRI confirms osteomyelitis of 2nd metatarsal head -no abscess, no soft tissue collection. ESR 88, CRP 6.4. Blood cultures × 2 pending. IR-guided bone biopsy scheduled tomorrow -holding antibiotics until culture obtained (patient is hemodynamically stable). Vascular surgery consulted for ABI assessment -pedal pulses palpable. Podiatry involved for wound care. Plan: bone biopsy → targeted antibiotics × 6 weeks, oral step-down when organism and sensitivities known. Glucose management with insulin drip per endocrine.
Monitoring Parameters
- ESR and CRP -check weekly. CRP normalizes faster (1–2 weeks). ESR may take weeks to decline. Failure to trend down suggests treatment failure or undrained collection.
- CBC with differential -weekly. Monitor WBC normalization.
- Vancomycin levels -if on vancomycin, target AUC/MIC 400–600. Check trough before 4th dose, then 1–2× weekly.
- Renal function (BMP) -weekly if on vancomycin or aminoglycosides. Watch for nephrotoxicity.
- LFTs -if on rifampin (hepatotoxic). Baseline then q2 weeks.
- PICC line site -daily inspection for infection, thrombosis if on prolonged IV therapy.
- Repeat imaging -not routine. Repeat MRI only if clinical concern for treatment failure or new collection. Imaging lags behind clinical improvement.
⚡ Summary
Get Tissue Before Antibiotics
Bone biopsy with culture is the diagnostic gold standard and directs 6 weeks of therapy. Superficial swabs grow colonizers and misdirect treatment. Hold antibiotics for the biopsy in a stable patient; treat empirically first only in sepsis or rapidly progressive infection.
Know the Two Routes of Infection
Hematogenous in children, typically long bone metaphysis, usually monomicrobial. Contiguous spread in adults, from diabetic foot ulcers, decubitus ulcers, post-surgical wounds and trauma, usually polymicrobial. S. aureus is the commonest organism in both. Vertebral osteomyelitis is the classic hematogenous form in adults and often follows bacteremia.
Use the Probe-to-Bone Test in Diabetic Feet
A sterile probe reaching bone through the ulcer has a positive predictive value of about 89%. Free, immediate, and better than most first-line imaging.
MRI Is the Imaging Gold Standard
It shows marrow edema early, defines the extent, and identifies abscess and epidural extension. Plain films are normal for the first 10 to 14 days, because 30 to 50% of bone mineral must be lost before a change is visible, so a normal x-ray early excludes nothing.
Six Weeks, With One Important Exception
Six weeks of targeted therapy is standard when infected bone remains. If all infected bone is resected, only 2 to 5 days of soft tissue coverage is needed, because the infected tissue is gone. Getting that distinction right saves weeks of unnecessary IV therapy after an amputation or complete debridement.
Oral Step-Down Is Non-Inferior
OVIVA showed oral therapy was non-inferior to IV for bone and joint infection when a well-absorbed agent with good bone penetration is available and the organism is susceptible. This avoids a PICC line and its infection and thrombosis risk, and it should be actively considered rather than defaulting to 6 weeks of IV.
Surgery Is Needed More Often Than People Expect
Debride for necrotic bone or sequestrum, drain abscesses, remove infected hardware, and stabilize instability. Chronic osteomyelitis with dead bone will not be cured by antibiotics alone, because there is no blood supply to carry the drug. Retained hardware usually needs removal or long-term suppression.
Follow Response and Look for the Source
Track CRP and the clinical picture rather than repeating MRI early, since imaging changes lag improvement by months and a persistent abnormality is not treatment failure. In vertebral osteomyelitis, get blood cultures and an echocardiogram, since it frequently arises from endocarditis, and watch for epidural abscess, where new neurologic symptoms mean emergent imaging and decompression.
Related Topics
Cellulitis & Skin InfectionsCLABSI & Line InfectionsDiabetic Foot InfectionFungal InfectionsHantavirus (HPS & HFRS)Herpes Simplex (HSV)